advancing innovation to save lives

A year in review: The global health innovation stories that shaped 2018

Two thousand eighteen was a turbulent year in global health. Between reemerging crises, breakthrough scientific discoveries, and the continued looming threat of health research funding cuts, 2018 took us on a roller coaster ride of peril and promise. As the new year begins, GHTC is taking a moment to look back and reflect on the global health innovation stories and news that shaped 2018.
Learn More

GHTC releases brief analyzing WHO draft roadmap for access

Following the release of the World Health Organization's (WHO) final draft of its Road Map for Access to Medicines, Vaccines and Other Health Products, GHTC has published a new policy brief analyzing the contents of the road map and the potential implications, if approved.
View

Member Spotlight: Elizabeth Glaser Pediatric AIDS Foundation

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) seeks to end global pediatric HIV/AIDS through prevention and treatment programs, research, and advocacy. EGPAF advocates for new drugs and diagnostics to better reach children living with HIV. EGPAF recently co-convened a High-Level Dialogue on Pediatric HIV at the Vatican to accelerate children’s access to lifesaving HIV diagnostics and medicines. EGPAF also implements and advocates for the expanded uptake of new and advanced technologies, such as Point of Care Early Infant Diagnostics (POC EID), to improve identification of children living with HIV and quickly link them to treatment. To learn more about EGPAF’s work click here.

Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more

CDC/James Gathany
GHTC responds to RFI on CARB National Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI)on the next National Action Plan for Combatting Antibiotic Resistant Bacteria (CARB) 2020-2025. GHTC’s submission encouraged the prioritization of R&D to combat antimicrobial resistance globally.

PDF

PATH/Patrick McKern
GHTC applauds passage of Global Health Innovation Act

GHTC applauds yesterday's Senate passage of the Global Health Innovation Act, a bipartisan bill to support efforts by the US Agency for International Development to develop affordable, appropriate technologies to advance the health of people in the world’s poorest places. The bill, which has already passed the House of Representatives, now heads to the President’s desk where he is expected to sign it into law.

Learn More
View All News & Events

Community Event

Global Health Security 2019
Global Health Security 2019
Australian Government, Indo-Pacific Centre for Health Security, Government of New South Wales, The University of Sydney
Learn More

Member Event

Policy Cures Research
Launch of the 2018 G-FINDER report
Policy Cures Research
Learn More
View All Events
PATH/Satvir Malhotra
Research Roundup: Single-dose Ebola drug, mosquito birth control, and new TB treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Satvir Malhotra
Research Roundup: Vaccines without chemicals, FDA fast track for Vanelva's chikungunya vaccine, and Marburg virus found in bats in West Africa

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide